Job description
The Respiratory, Immunology and Inflammation Translational Unit (RIITU), within the RIIRU therapy area, is accountable for end‑to‑end disease area translational science to inform program-level biomarker strategies from preclinical to launch. This includes generation of foundational data, disease biomarker development and validation, and deployment of tools/biomarkers to support Proof of Mechanism, signs of clinical efficacy, Proof of Concept, and pairing mechanisms of action with patient subtypes to predict responder populations. We are looking for a dynamic individual to excel in the following responsibilities.
This role is based in the United Kingdom or the United States and follows a hybrid working model. You will be expected to work on site regularly to collaborate with your team and partners.
The US salary ranges take into account location within the US market, the candidate’s skills, experience, education level and the market rate for the role. The position also offers an annual bonus and eligibility to participate in a share‑based long‑term incentive program. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information, military service or any basis prohibited under federal, state or local law.
Please note that if you have any adjustments required contact us at UKRecruitment.Adjustments@gsk.com
#J-18808-Ljbffr
